Vaccine effectiveness in pandemic influenza - primary care reporting (VIPER): an observational study to assess the effectiveness of the pandemic influenza A (H1N1)v vaccine.

Health Technology Assessment : HTA
Colin R SimpsonJ McMenamin

Abstract

To determine influenza A (H1N1)v vaccine effectiveness (VE) in the Scottish population at an early stage of the 2009-10 H1N1v vaccination programme, using a sentinel surveillance network of 41 general practices contributing to the Practice Team Information (PTI) network. Retrospective cohort study using record linkage. Using the Community Health Index (CHI) number, general practice patient-level data were extracted and linked to the Scottish Morbidity Record (SMR) catalogue, containing information on all inpatient hospitalisations in Scotland. The Health Protection Scotland (HPS) data set was also used, consisting of laboratory-confirmed cases of influenza A (H1N1)v from the practices. The study involved a longitudinal evaluation of the aspect of the influenza A (H1N1)v vaccination programme implemented through general practice in autumn/winter 2009. At 25 December 2009, vaccine uptake estimates for the study population were 12.0% (95% CI 11.9 to 12.1). For those patients in an at-risk group (n = 59,721), the uptake rate was 37.5% (95% CI 37.1 to 37.9). Among the 1492 patients swabbed, 467 were positive for H1N1, giving a positivity rate of 31.3% [95% confidence interval (CI) 29.0 to 33.7]. Among those in a clinical risk group ...Continue Reading

Citations

Apr 8, 2011·Emerging Infectious Diseases·Joanne E EnstoneJonathan S Nguyen-Van-Tam
Jan 29, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·N ReintonA Moghaddam
Nov 26, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Harshad P PatilAnke Huckriede
Jul 17, 2012·Vaccine·Angela DomínguezUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain
Dec 25, 2010·Vaccine·Cristina Rodríguez-RieiroRodrigo Jiménez-García
Mar 6, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·C R SimpsonJ McMenamin
Jul 25, 2014·PloS One·Domino DetermannEsther W de Bekker-Grob
Nov 19, 2010·PloS One·Laura Matrajt, Ira M Longini
Nov 10, 2012·Journal of Theoretical Biology·Jeehyun LeeHee-Dae Kwon
Sep 17, 2016·Human Vaccines & Immunotherapeutics·Nathalie Garçon, Alberta Di Pasquale
Jul 15, 2015·Journal of the Royal Society of Medicine·Colin R SimpsonUNKNOWN SHELS researchers
Mar 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jesús CastillaUNKNOWN CIBERESP Cases and Controls in Influenza Working Group Spain
Feb 14, 2018·Influenza and Other Respiratory Viruses·Catherine L KingJulie Leask
Apr 22, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ake OrtqvistBo Svenungsson
Jul 10, 2012·Journal of the Royal Society, Interface·E GoldsteinM Lipsitch
Apr 11, 2014·The Cochrane Database of Systematic Reviews·Tom JeffersonCarl J Heneghan
Jan 24, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Woolf T WalkerAndrew J Pollard
Jan 23, 2013·The Pediatric Infectious Disease Journal·Angela DomínguezUNKNOWN CIBERESP Cases and Controls in Pandemic Influenza Working Group Spain
Jun 6, 2021·International Journal of Epidemiology·Rachel H MulhollandAziz Sheikh
Sep 17, 2021·Health Security·Gregory N JasaniStephen Y Liang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.